A very special moment on CNBC between Meg and Mel, discussing why $JNJ' s phase one vaccine trial is 1000 people, and $MRNA had only 45. 

Mel implies it is because JNJ is so far behind.

Meg wonders if it could be a "different approach."

@CGrantWSJ @WallStCynic @DonutShorts